Citadel Advisors’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.27M | Buy |
+7,942
| New | +$1.22M | ﹤0.01% | 7137 |
|
|
2025
Q3 | – | Sell |
-11,466
| Closed | -$1.24M | – | 13655 |
|
|
2025
Q2 | $1.23M | Buy |
11,466
+5,231
| +84% | +$523K | ﹤0.01% | 6650 |
|
|
2025
Q1 | $579K | Buy |
+6,235
| New | +$604K | ﹤0.01% | 8160 |
|
|
2024
Q4 | – | Sell |
-2,282
| Closed | -$287K | – | 15098 |
|
|
2024
Q3 | $287K | Sell |
2,282
-3,533
| -61% | -$444K | ﹤0.01% | 9426 |
|
|
2024
Q2 | $630K | Buy |
5,815
+2,645
| +83% | +$258K | ﹤0.01% | 7570 |
|
|
2024
Q1 | $300K | Sell |
3,170
-6,260
| -66% | -$593K | ﹤0.01% | 9450 |
|
|
2023
Q4 | $872K | Sell |
9,430
-9,324
| -50% | -$715K | ﹤0.01% | 6949 |
|
|
2023
Q3 | $1.2M | Sell |
18,754
-39,812
| -68% | -$2.55M | ﹤0.01% | 6197 |
|
|
2023
Q2 | $3.62M | Sell |
58,566
-41,921
| -42% | -$2.49M | ﹤0.01% | 4149 |
|
|
2023
Q1 | $5.84M | Buy |
100,487
+59,343
| +144% | +$3.41M | ﹤0.01% | 3551 |
|
|
2022
Q4 | $2.45M | Buy |
41,144
+35,078
| +578% | +$2.13M | ﹤0.01% | 5110 |
|
|
2022
Q3 | $384K | Sell |
6,066
-5,493
| -48% | -$382K | ﹤0.01% | 9033 |
|
|
2022
Q2 | $808K | Buy |
+11,559
| New | +$810K | ﹤0.01% | 7524 |
|
|
2021
Q3 | – | Sell |
-14,494
| Closed | -$1.01M | – | 14371 |
|
|
2021
Q2 | $1.01M | Buy |
+14,494
| New | +$1.05M | ﹤0.01% | 8337 |
|
|
2021
Q1 | – | Sell |
-8,847
| Closed | -$588K | – | 13542 |
|
|
2020
Q4 | $588K | Sell |
8,847
-6,734
| -43% | -$444K | ﹤0.01% | 7852 |
|
|
2020
Q3 | $970K | Buy |
15,581
+10,673
| +217% | +$668K | ﹤0.01% | 6084 |
|
|
2020
Q2 | $311K | Sell |
4,908
-3,341
| -41% | -$224K | ﹤0.01% | 7852 |
|
|
2020
Q1 | $592K | Buy |
8,249
+187
| +2% | +$14.8K | ﹤0.01% | 6189 |
|
|
2019
Q4 | $697K | Buy |
+8,062
| New | +$674K | ﹤0.01% | 6253 |
|
|
2019
Q3 | – | Sell |
-4,742
| Closed | -$385K | – | 9566 |
|
|
2019
Q2 | $385K | Sell |
4,742
-116
| -2% | -$8.95K | ﹤0.01% | 7204 |
|
|
2019
Q1 | $369K | Buy |
+4,858
| New | +$385K | ﹤0.01% | 7297 |
|
|
2018
Q4 | – | Sell |
-12,637
| Closed | -$952K | – | 9555 |
|
|
2018
Q3 | $952K | Buy |
12,637
+2,605
| +26% | +$192K | ﹤0.01% | 5647 |
|
|
2018
Q2 | $707K | Buy |
10,032
+2,682
| +36% | +$175K | ﹤0.01% | 5809 |
|
|
2018
Q1 | $438K | Buy |
7,350
+93
| +1% | +$5.7K | ﹤0.01% | 6122 |
|
|
2017
Q4 | $442K | Sell |
7,257
-6,284
| -46% | -$401K | ﹤0.01% | 5843 |
|
|
2017
Q3 | $848K | Sell |
13,541
-2,070
| -13% | -$133K | ﹤0.01% | 4544 |
|
|
2017
Q2 | $1.09M | Sell |
15,611
-4,900
| -24% | -$350K | ﹤0.01% | 3963 |
|
|
2017
Q1 | $1.46M | Buy |
+20,511
| New | +$1.52M | ﹤0.01% | 3459 |
|
|
2016
Q4 | – | Sell |
-4,762
| Closed | -$314K | – | 7651 |
|
|
2016
Q3 | $314K | Buy |
+4,762
| New | +$309K | ﹤0.01% | 5605 |
|
|
2016
Q1 | – | Sell |
-3,519
| Closed | -$217K | – | 7573 |
|
|
2015
Q4 | $217K | Buy |
+3,519
| New | +$228K | ﹤0.01% | 5701 |
|
Other funds holding NHC
MSIIA
VPM
VCM
MHS
Citadel Advisors's NHC Position: Q1 2026 in Review
Citadel Advisors opened a new position in National Healthcare (NHC) in Q1 2026: 7,942 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #7137 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NHC as recently as Q2 2025.
Citadel Advisors first reported a position in NHC in Q4 2015 and has held it in 30 quarters since. The position peaked at $5.84M in Q1 2023. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.
- Citadel Advisors held 7,942 shares of National Healthcare worth $1.27M as of Q1 2026.
- National Healthcare was a new Citadel Advisors position in Q1 2026.
- National Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7137 holding.
- Citadel Advisors first reported a position in National Healthcare in Q4 2015 and has held it in 30 quarters since.
- Citadel Advisors's National Healthcare position peaked at $5.84M in Q1 2023.
- 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.